Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Urinary antiseptics are a class of drugs specifically designed to exert antibacterial activity within the urinary tract, targeting bacteria responsible for urinary tract infections (UTIs). They achieve high concentrations in urine but low levels elsewhere in the body. Common agents include methenamine (which releases formaldehyde in acidic urine) and nitrofurantoin (which disrupts multiple bacterial cell functions). They are primarily used for treating and preventing lower urinary tract infections, and for long-term suppression of bacteriuria.
Varies by agent: Methenamine releases formaldehyde in acidic urine, disrupting bacterial proteins and DNA. Nitrofurantoin is converted into reactive intermediates that disrupt multiple bacterial cellular processes. Quinolone derivatives (nalidixic acid, oxolinic acid) inhibit bacterial DNA replication enzymes.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Urinary Antiseptics (N/A).